文献速递湿疹皮炎与荨麻疹

湿疹控制回顾(RECAP)工具在荷兰语、英语和德语版中的内容效度:一项针对青少年特应性湿疹患者的认知访谈研究

Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study.
PubMed 文献 · Br J Dermatol · 2022-08-19

本研究通过23例8-16岁特应性湿疹患者的半结构化认知访谈,评估RECAP自评版在英语、德语和荷兰语中的内容效度。结果显示8-11岁儿童在问卷最后三个条目上存在年龄相关的理解困难,12岁及以上青少年可独立完成自评版;德语版经翻译调整后或适用于8岁儿童。

要点

  • RECAP自评版在12岁及以上青少年中具有足够的内容效度。
  • 8-11岁儿童在最后三个条目上存在理解困难,需帮助完成。
  • 德语版经翻译调整后或可用于8岁儿童。

核心结论

  • RECAP自评版适用于12岁及以上青少年,代理版可用于12岁以下儿童。
  • 其他测量属性需进一步研究。

研究设计与样本

  • 在德国和荷兰的皮肤科诊所、英国通过社交媒体和现有邮件列表招募8-16岁特应性湿疹患者,共进行23例半结构化认知访谈,采用出声思考法。

主要发现

  • 8-11岁青少年在问卷最后三个条目上出现显著的年龄相关理解问题,无帮助时完成RECAP有困难;年龄较大的儿童仅有轻微问题,能自行完成问卷。
  • RECAP自评版在12岁及以上青少年中具有足够的内容效度供自评完成。
  • 德语版经一些翻译调整后或适用于8岁儿童。
  • 某些情况下年龄较大的儿童也可能需要代理版。

关键数值与推荐

  • 推荐12岁及以上青少年使用荷兰语、英语和德语版RECAP自评版。
  • 12岁以下儿童或认知或身体上无法报告湿疹控制体验的儿童可使用代理版。
  • 照护者应尽可能与孩子一起完成RECAP。

临床怎么用

  • 推荐12岁及以上青少年使用荷兰语、英语和德语版RECAP自评版。
  • 12岁以下儿童或认知或身体上无法报告湿疹控制体验的儿童可使用代理版。
  • 照护者应尽可能与孩子一起完成RECAP。

局限性

  • 其他测量属性需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recap of atopic eczema (RECAP) is a patient-reported outcome measure assessing eczema control. This instrument has been developed and validated in the UK. There are self-reported and proxy-reported versions in English, Dutch and German. However, it is unclear whether the self-reported version shows adequate content validity when completed by young people (8-16 years) in these languages. OBJECTIVES: To assess the content validity (comprehensibility, relevance and comprehensiveness) of the English, German and Dutch versions of the self-reported RECAP in young people with atopic eczema and to identify the most appropriate age cutoff for self-completion. METHODS: We conducted 23 semistructured cognitive interviews with young people aged 8-16 years, using the 'think-aloud' method. In Germany and the Netherlands, participants were recruited in dermatology clinics and in the UK through social media and existing mailing lists. Interviews were audio recorded, transcribed verbatim and analysed in the three languages, using a problem-focused coding manual. Transcripts were coded by two independent reviewers in each country. Themes were translated into English and compared across the three countries. RESULTS: Significant age-related comprehensibility issues with the last three items of the questionnaire occurred with young people aged 8-11 years, causing difficulties completing RECAP without help. However, older children had only minor problems and were able to complete the questionnaire by themselves. The self-reported version of RECAP has sufficient content validity for self-completion in young people aged 12 years and above. However, the German version with some translational adaptations may be appropriate for children from the age of 8 years. There may be some situations where the proxy version is needed for older children too. CONCLUSIONS: The self-reported version of RECAP is appropriate for use from the age of 12 years. The proxy version can be used in children younger than 12 years. Other measurement properties should be further investigated. What is already known about this topic? Recap of atopic eczema (RECAP) is an instrument recommended by the Harmonising Outcome Measures for Eczema initiative for the core outcome domain of long-term control of atopic eczema. Content validity of RECAP for self-completion by adults and of the proxy version has been assessed. What does this study add? In this study, content validity (comprehensibility, relevance and comprehensiveness) of the self-reported version of RECAP among young people (aged 8-16 years) with atopic eczema across the UK, Germany and the Netherlands is assessed. Based on these findings, key recommendations on how to measure eczema control in young people with atopic eczema are formulated. What are the clinical implications of this work? The Dutch, English and German self-completion versions of RECAP are recommended for use in adolescents from the age of 12 years. The proxy version could be used in children younger than 12 years or where children are cognitively or physically incapable of reporting their experience of eczema control. Caregivers should be encouraged to complete RECAP together with their child where possible.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Gabes M, Ragamin A, Baker A, et al. Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study. Br J Dermatol. 2022. PMID: 35842231. doi:10.1111/bjd.21767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。